TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/19/23 08:34 | 5/17/23 | CERT | Certara, Inc. | DE | Tech | Softw | Prepackaged Software | Collins Cynthia | NJ | D | M.d | 0 | 0.00 | 0 | 9 | 141 | 15 | D | |||||||||||||||
2/10/21 16:26 | 2/9/21 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Collins Cynthia | MA | O | CEO | S | -84 | 66.65 | 0 | -1 | -3 | 44 | D | ||||||||||||||
8/21/20 16:12 | 8/20/20 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Collins Cynthia | MA | DO | CEO | S | -72 | 36.66 | 0 | -2 | -4 | 45 | D | ||||||||||||||
1/3/20 12:04 | 12/31/19 | DMTK | Dermtech, Inc. | Health | Health | Medical Laboratories | Collins Cynthia | CA | D | M.d | 0 | 0.00 | 0 | 9 | 82 | 19 | D | ||||||||||||||||
8/21/19 16:03 | 8/19/19 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Collins Cynthia | MA | DO | CEO | S | -134 | 25.83 | 0 | -5 | -31 | 11 | D | ||||||||||||||
1/6/09 17:46 | 1/5/09 | BEC | Beckman Coulter Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Collins Cynthia | CA | O | Group VP | S | -9 | 44.32 | 0 | 0 | -2 | 9 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |